SCHEMBL5312705

SCHEMBL5312705

[CH2]c1ccoc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8529510 0.69
SCHEMBL115390 0.69
Hydrochloric Acid SCHEMBL29135193 0.67
SCHEMBL9824928 0.65
SCHEMBL8008537 0.65
SCHEMBL11522722 0.65
SCHEMBL691744 0.65
SCHEMBL5678348 0.65
SCHEMBL6256428 0.65
SCHEMBL1454914 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP claimed
CN-117281118-A Application of furancarboxylic acid in preparation of nematodc resisting agent 中国科学院海洋研究所 2023-12-26 CN disclosed
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP disclosed
CN-108853098-A The application of N- (2- furfuryl) -3- tolimidazole and thiazole carboxamides 山东大学齐鲁医院 2018-11-23 CN disclosed
CN-1976932-A Fused quinoline derivative and use thereof TAKEDA PHARMACEUTICAL (JP) 2007-06-06 CN disclosed
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
CN-1070192-C Thipyridines for use in control of helicobacter bacteria BYK GULDEN LOMBERG CHEM FAB (DE) 2001-08-29 CN disclosed
CN-1065244-C Tricyclic benzazepine vasopressin antagonists AMERICAN CYANAMID CO (US) 2001-05-02 CN disclosed
CN-1018614-B Process for preparing antihistaminic compositions containing N-heterocyclyl-4-piperidinamines JANSSEN PHARMACEUTICA NV (BE) 1992-10-14 CN disclosed
EP-0228192-A2 Renin-inhibitory oligopeptides, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-07-08 EP disclosed
EP-0186977-A2 Renin-inhibitory dipeptides, their preparation and use SANKYO COMPANY LIMITED (JP) 1986-07-09 EP disclosed
EP-0035228-B1 TETRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND ANTI-ULCER COMPOSITION CONTAINING THE SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 EP disclosed
EP-0028717-B1 6,7-BENZOMORPHAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ACF CHEMIEFARMA NV (NL) 1984-08-15 EP disclosed
US-4425353-A Analgesic 5-oxygenated-6,7-benzomorphan derivatives ACF CHEMIEFARMA NV (NL) 1984-01-10 US disclosed
US-4406904-A Method of inhibiting luteinizing hormone secretion with 6,7-benzomorphan derivatives ACF CHEMIEFARMA NV (NL) 1983-09-27 US disclosed
US-4372953-A Tetrazole derivatives, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1983-02-08 US disclosed
EP-0035228-A1 Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1981-09-09 EP disclosed
EP-0028717-A1 6,7-Benzomorphan derivatives, processes for their production, pharmaceutical compositions containing said derivatives and their use as pharmaceuticals ACF CHEMIEFARMA NV (NL) 1981-05-20 EP disclosed